Stockreport

Insmed stocks soar as Phase III lung disease drug exceeds expectations [Yahoo! Finance]

Insmed Incorporated  (INSM) 
Last insmed incorporated earnings: 4/30 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.insmed.com
PDF The highly anticipated ASPEN trial (NCT04594369) was a global, randomised, double-blind, placebo-controlled Phase III study to assess the efficacy, safety, and tolerabi [Read more]